halothane has been researched along with Coronary Artery Disease in 1 studies
Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaplan, JA | 1 |
| Guffin, AV | 1 |
| Mikula, S | 1 |
| Dolman, J | 1 |
| Profeta, J | 1 |
1 trial available for halothane and Coronary Artery Disease
| Article | Year |
|---|---|
Comparative hemodynamic effects of propofol and thiamylal sodium during anesthetic induction for myocardial revascularization.
Topics: Adult; Aged; Anesthesia, Intravenous; Anesthetics, Combined; Anesthetics, Inhalation; Anesthetics, I | 1988 |